Solid IO
Founded 2025 · 13 employees on LinkedIn · 5 known investors
Find your way into Solid IO
Solid IO develops a tumor-on-chip platform using organ-on-chip technology and AI to model patient-specific tumor microenvironments for oncology and immunotherapy research. The platform enables pharmaceutical companies, biotech firms, and cancer clinics to predict treatment responses, accelerate drug development, and support precision medicine in cancer care.
Investors · 5
Leo Capital✓ verifiedSan Franciscovia Ricky Moezinia · inferred
BSV VenturesVilnius · $5K – $430K
Leo Capital VenturesSingapore
Nordic Science InvestmentsHelsinki · $55K – $3.9M
Also in the syndicate · 1
Helsinki University Funds
Funding
SEC filings, press & company announcements- Undisclosed amountfirst funding roundFeb 2025 · 2 sources
Nordic Science Investments (lead), BSV Ventures, Helsinki University Funds
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Solid IO do?
- Solid IO develops a tumor-on-chip platform using organ-on-chip technology and AI to model patient-specific tumor microenvironments for oncology and immunotherapy research. The platform enables pharmaceutical companies, biotech firms, and cancer clinics to predict treatment responses, accelerate drug development, and support precision medicine in cancer care.
- Who are Solid IO's investors?
- Solid IO's investors include Leo Capital, BSV Ventures, Leo Capital Ventures, Nordic Science Investments.